Humana Inc. (HUM) Return on Invested Capital (ROIC): 3.12%
Is Humana Inc.’s return on invested capital (ROIC) high or low?
Humana Inc.'s return on invested capital (ROIC) of 3.12% is 56% below its 5-year average of 7.01%, near the low end of its 5-year range (3.12%–12.56%).
As of Monday, June 15, 2026. 4.15% below its 12-month average of 3.25%.
HUM Return on Invested Capital (ROIC) Chart
HUM Average Return on Invested Capital (ROIC) Chart
HUM Current vs Average Return on Invested Capital (ROIC) Chart
HUM Return on Invested Capital (ROIC) Metrics
RETURN ON INVESTED CAPITAL (ROIC)
3.12%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
3.25%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
5.37%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
7.01%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
7.32%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
7.79%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
7.94%
CURRENT VS TTM AVG
-4.15%
CURRENT VS 3Y AVG
-41.85%
CURRENT VS 5Y AVG
-55.51%
CURRENT VS 10Y AVG
-57.39%
CURRENT VS 15Y AVG
-59.94%
CURRENT VS 20Y AVG
-60.71%
HUM Competitors' Return on Invested Capital (ROIC)
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Humana Inc. (HUM) | $45.65B | 3.12% | 3.25% | 5.37% | 7.01% |
| IDEXX Laboratories, Inc. (IDXX)vs › | $44.93B | 40.27% | 37.07% | 34.89% | 35.94% |
| Becton, Dickinson and Company (BDX)vs › | $52.72B | 4.73% | 4.38% | 4.32% | 3.88% |
| Cardinal Health, Inc. (CAH)vs › | $53.02B | 11.37% | 10.09% | 4.86% | -0.22% |
| Agilent Technologies, Inc. (A)vs › | $36.89B | 12.57% | 12.57% | 13.57% | 12.73% |
| Cencora, Inc. (COR)vs › | $54.76B | 13.23% | 15.09% | 14.58% | 13.58% |
| Zoetis Inc. (ZTS)vs › | $33.37B | 21.54% | 21.87% | 20.30% | 19.27% |
| Medline Inc. (MDLN)vs › | $31.57B | 5.69% | 6.03% | 3.95% | 3.95% |
| Centene Corporation (CNC)vs › | $30.48B | -13.41% | -4.17% | -0.53% | 0.76% |
| IQVIA Holdings Inc. (IQV)vs › | $29.63B | 8.23% | 8.41% | 8.23% | 6.99% |
Capital Efficiency
ROIC
3.1%
ROE
6.1%
Humana Inc. Return on Invested Capital (ROIC) Formula & Definition
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Humana Inc. Return on Invested Capital (ROIC) FAQ
- What is the return on invested capital (ROIC) for Humana Inc. (HUM)?
- The return on invested capital (ROIC) for HUM stock is 3.12%.
- Is Humana Inc.'s return on invested capital (ROIC) high or low?
- Humana Inc.'s return on invested capital (ROIC) of 3.12% is 56% below its 5-year average of 7.01%, near the low end of its 5-year range (3.12%–12.56%).
- What is the TTM average return on invested capital (ROIC) for Humana Inc. (HUM)?
- The TTM average return on invested capital (ROIC) for HUM stock is 3.25%.
- What is the 3Y average return on invested capital (ROIC) for Humana Inc. (HUM)?
- The 3Y average return on invested capital (ROIC) for HUM stock is 5.37%.
- What is the 5Y average return on invested capital (ROIC) for Humana Inc. (HUM)?
- The 5Y average return on invested capital (ROIC) for HUM stock is 7.01%.
- What is the 10Y average return on invested capital (ROIC) for Humana Inc. (HUM)?
- The 10Y average return on invested capital (ROIC) for HUM stock is 7.32%.
- What is the 15Y average return on invested capital (ROIC) for Humana Inc. (HUM)?
- The 15Y average return on invested capital (ROIC) for HUM stock is 7.79%.
- What is the 20Y average return on invested capital (ROIC) for Humana Inc. (HUM)?
- The 20Y average return on invested capital (ROIC) for HUM stock is 7.94%.
Humana Inc. Return on Invested Capital (ROIC) History
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | 3.12% |
| 2024-12-31 | 3.39% |
| 2023-12-31 | 6.79% |
| 2022-12-31 | 8.16% |
| 2021-12-31 | 8.06% |
| 2020-12-31 | 12.56% |
| 2019-12-31 | 11.74% |
| 2018-12-31 | 8.20% |
| 2017-12-31 | 9.02% |
| 2016-12-31 | 3.28% |
| 2015-12-31 | 6.23% |
| 2014-12-31 | 6.71% |
| 2013-12-31 | 7.92% |
| 2012-12-31 | 8.50% |
| 2011-12-31 | 10.71% |
| 2010-12-31 | 10.21% |
| 2009-12-31 | 10.36% |
| 2008-12-31 | 7.99% |
| 2007-12-31 | 8.82% |
| 2006-12-31 | 7.05% |
| 2005-12-31 | 25.38% |
| 2004-12-31 | 7.89% |
| 2003-12-31 | -10.94% |
| 2002-12-31 | -6.72% |
| 2001-12-31 | -6.19% |
| 2000-12-31 | -4.70% |
| 1999-12-31 | -42.44% |
| 1998-12-31 | 26.67% |
| 1997-12-31 | 0.00% |
| 1996-12-31 | 0.00% |
Related Metrics
About Humana Inc.
Humana Inc., a prominent health and well-being enterprise, operates across the United States through its various subsidiary companies. Its operational structure is divided into three main segments: Retail, Group and Specialty, and Healthcare Services. The firm provides a wide array of medical and supplementary insurance plans directly to individual consumers. Furthermore, Humana collaborates with government entities; it holds a contract with the Centers for Medicare and Medicaid Services (CMS) to manage the Limited Income Newly Eligible Transition (LI NET) prescription drug program. The company also secures agreements with numerous states to deliver Medicaid, dual-eligible, and long-term care support benefits. For employer groups and individuals, Humana furnishes fully insured commercial medical and specialized health coverage, which encompasses dental, vision, and other ancillary health benefits. They additionally offer administrative services only (ASO) solutions and extend support to military personnel through contracts like the TRICARE T2017 East Region. Beyond insurance products, the company delivers comprehensive healthcare services directly. These include pharmacy management, provider network services, and a suite of home-based solutions such as home health care, serving both its own health plan enrollees and external clients. By the close of 2021 (December 31), Humana's reach extended to approximately 17 million individuals enrolled in its medical benefit plans and an additional 5 million utilizing its specialized product offerings. Established in 1961, Humana Inc. maintains its corporate headquarters in Louisville, Kentucky.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- CEO
- James A. Rechtin